Alendronat Teva Tafla 70 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

alendronat teva tafla 70 mg

teva b.v.* - acidum alendronicum natríum - tafla - 70 mg

Cyklokapron Filmuhúðuð tafla 500 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

cyklokapron filmuhúðuð tafla 500 mg

viatris aps - acidum tranexamicum inn - filmuhúðuð tafla - 500 mg

Hjartamagnýl Magasýruþolin tafla 75 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

hjartamagnýl magasýruþolin tafla 75 mg

teva b.v.* - acidum acetylsalicylicum - magasýruþolin tafla - 75 mg

Fucidin Smyrsli 20 mg/g আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

fucidin smyrsli 20 mg/g

leo pharma a/s* - natrii fusidas nfn - smyrsli - 20 mg/g

Lojuxta ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

lojuxta

amryt pharmaceuticals dac - lomitapide - kólesterólhækkun - lipid breytandi lyf - hvert er ætlað sem viðbót til að lágt‑feitur mataræði og öðrum fitu‑lækka lyf með eða án lágt-þéttleiki-lípóprótein (gegn) apheresis í fullorðinn sjúklinga með tilbúin ættingja hypercholesterolaemia (hofh). erfðafræðilega staðfestingu á hofh ætti að vera fæst þegar það er mögulegt. annars konar aðal hyperlipoproteinaemia og efri veldur hypercholesterolaemia (e. nýrungaheilkenni, of) verður að vera útilokað.

DuoPlavin ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

duoplavin

sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - blóðþurrðandi lyf - duoplavin er ætlað til að koma í veg fyrir beinþrýstingslækkandi aukaverkanir hjá fullorðnum sjúklingum sem taka bæði klópídógrel og asetýlsalisýlsýru (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. nánari upplýsingar er að vísa til kafla 5.

Ucedane ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

ucedane

eurocept international bv - carglumic acid - hyperammonemia; amino acid metabolism, inborn errors - Önnur meltingarvegi og efnaskipti vörur, - ucedane is indicated in treatment of:hyperammonaemia due to n-acetylglutamate synthase primary deficiency;hyperammonaemia due to isovaleric acidaemia;hyperammonaemia due to methymalonic acidaemia;hyperammonaemia due to propionic acidaemia.

Xylocain Stungulyf, lausn 10 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain stungulyf, lausn 10 mg/ml

aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 10 mg/ml

Xylocain Stungulyf, lausn 20 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain stungulyf, lausn 20 mg/ml

aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 20 mg/ml

Xylocain adrenalin Stungulyf, lausn 10 mg/ml+5 míkróg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain adrenalin stungulyf, lausn 10 mg/ml+5 míkróg/ml

aspen pharma trading limited - lidocainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 10 mg/ml+5 míkróg/ml